CEACAM5 and colorectal carcinoma: In the present study, we prospectively analyzed both the biomarker chip and serum CEA level detection periodically after curative resection in Union for International Cancer Control (UICC)/American Joint Committee on Cancer stage I–III CRC patients and identified whether the biochip was more efficient for their postoperative surveillance.